you don't think there are a number of companies/investors that would jump into bed with that?
Actually, I don’t think there are any companies who are especially interested in laViv because the high-cost business model is inherently flawed. I could be wrong, of course, but my track record of iHub calls in the aesthetic-medicine arena is quite good.